Erythropoietin Supports the Survival of Prostate Cancer, But Not Growth and Bone Metastasis

Erythropoietin (Epo) is used in clinical settings to enhance hematopoietic function and to improve the quality of life for patients undergoing chemotherapy by reducing fatigue and the need for transfusions. However, several meta-analyses have revealed that Epo treatments are associated with an incre...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shiozawa, Yusuke, McGee, Samantha, Pienta, Michael J., McGregor, Natalie, Jung, Younghun, Yumoto, Kenji, Wang, Jingcheng, Berry, Janice E., Pienta, Kenneth J., Taichman, Russell S.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978144/
https://ncbi.nlm.nih.gov/pubmed/23696192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.24592
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items